Skip to content

Author

Peixin Tan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

SLight-Net: a lightweight spectral-layer aware network for retinal disease detection based on optical coherence tomography

Background Retinal diseases are a major cause of preventable visual impairment, and optical coherence tomography (OCT) provides high-resolution cross-sectional imaging for retinal assessment. However, reliable interpretation of OCT B-scans remains challenging because of speckle noise, subtle layer-wise changes, and visually similar pathological patterns. Methods We propose SLight-Net, a lightweight spectral-layer aware network for retinal OCT classification. The model is built on a compact three-stage convolutional backbone and incorporates two OCT-specific modules. The Frequency-Aware Spectral-Spatial Encoder (FASE) integrates local convolution, dilated contextual modeling, and learnable spectral modulation to capture multi-scale structural and frequency-aware retinal features. The Retinal Layer Depth Attention (RLDA) module further introduces a depth-direction anatomical prior to recalibrate feature responses along retinal layers. Deep supervision and exponential moving-average weight updating are used to improve optimization stability. Results On the OCT-C8 benchmark, SLight-Net achieves 98.21% classification accuracy with only 1.204M parameters. Additional evaluation on OCT2017 shows 99.30% accuracy, suggesting that the model maintains stable performance under a different class setting while remaining compact. Conclusion These findings indicate that OCT-specific spectral and layer-aware priors can support efficient retinal disease classification without relying on large generic backbones, providing a practical basis for lightweight computer-aided OCT analysis.

Yixiang Yao, Jin Hong, Rongli Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.